LEXARIA BIOSCIENCE CORP. Accounts Payable, Trade, Current
LEXARIA BIOSCIENCE CORP. (LEXX) had Accounts Payable, Trade, Current of $87.37 thousand as of 2019-05-31, per its 10-Q filed 2019-07-08.
Discontinued › Notes › Accounts Payable, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2019-07-08
- 2019-05-31: Accounts Payable, Trade, Current $87.37K.
- 2019-02-28: Accounts Payable, Trade, Current $26.02K.
- 2018-08-31: Accounts Payable, Trade, Current $33.92K; Accounts Payable, Trade, Current as first filed $30.49K.
| Period end | Accounts Payable, Trade, Current | Accounts Payable, Trade, Current as first filed |
|---|---|---|
| 2019-05-31 | $87.37K 10-Q · filed 2019-07-08 | |
| 2019-02-28 | $26.02K 10-Q · filed 2019-04-15 | |
| 2018-08-31 | $33.92K 10-Q · filed 2019-07-08 | $30.49K 10-Q · filed 2019-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |